Related Experiment Video
Updated: Jun 7, 2025

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
A 72-Year-Old Man With Innumerable Bilateral Pulmonary Nodules After Lung Transplantation.
Marwan Mashina1, Amir M Emtiazjoo1, Mindaugus Rackauskas2
1Lung Transplant and ECMO Program, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL.
A lung transplant recipient developed new symptoms post-surgery. This case highlights potential post-transplant complications in immunocompromised patients.
Area of Science:
- Medicine
- Immunology
- Transplantation
Background:
- Lung transplantation is a life-saving procedure for end-stage lung disease.
- Immunosuppression is critical to prevent organ rejection but increases infection risk.
Observation:
- A 72-year-old bilateral orthotropic lung transplant recipient presented with cough, dyspnea, and back pain 6 months post-transplant.
- The patient had a complex serostatus for cytomegalovirus (CMV) and Epstein-Barr virus (EBV) with the donor and recipient.
- He was on a standard immunosuppressive regimen including tacrolimus, mycophenolate mofetil, and prednisone.
Findings:
- The patient's presentation suggests a potential post-transplant complication.
- Differential diagnoses include infection, rejection, or other inflammatory processes.
- Further investigation is needed to determine the etiology of the symptoms.
Implications:
- This case underscores the importance of vigilant monitoring for complications in lung transplant recipients.
- Understanding donor-recipient serostatus for viruses like CMV and EBV is crucial.
- Timely diagnosis and management are essential for favorable outcomes in transplant patients.
More Related Videos
06:03Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
Published on: May 23, 2015
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: